B. Fife

Immunology · 2006–2009

A researcher in the Science corpus: 3 papers; trusts 5 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom B. Fife trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Taku Okazaki
  2. G. Freeman
  3. J. Bluestone
  4. Arlene H. Sharpe
  5. Q. Tang
  6. M. Keir
  7. R. Parry
  8. L. Williams
  9. M. Butte

Who trusts B. Fife overall

  1. James L. Riley
  2. E. Buchbinder
  3. D. Pardoll

Papers from B. Fife's perspective

Ordered by how strongly the researchers B. Fife trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. (Science)
  2. PD‐1:PD‐L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL‐2 (European Journal of Immunology)
  3. Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity. (Cancer Research)
  4. Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation (Journal of Experimental Medicine)
  5. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. (Immunity)
  6. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine (Proceedings of the National Academy of Sciences of the United States of America)
  7. The PD-1-PD-L pathway in immunological tolerance. (Trends in immunology)
  8. The B7 family revisited. (Annual Review of Immunology)
  9. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression (Nature)
  10. CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms (Molecular and Cellular Biology)

Their papers